Skip to main content Accessibility help
×
×
Home
  • Print publication year: 2015
  • Online publication date: April 2015

Chapter 13 - Colposcopy

from Section 1 - Ambulatory office practice
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Clinical Gynecology
  • Online ISBN: 9781139628938
  • Book DOI: https://doi.org/10.1017/CBO9781139628938
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

1. HinselmannH. Verbesserung der inspektionsmoglichkeiten von Vulva Vagina and Portio. [Improvement of inspection facility of vulva, vagina and porto.] Muchner Med Wochenschr 1925: 72:1733–1742.
2. KurmanRJ, HensonDE, HerbstAL, et al. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1886–1869.
3. CoxJT, SchiffmanM, SolomonD. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406–1412.
4. GuidoR, SchiffmanM, SolomonD, BurkeL, Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance; a two-year prospective study. Am J Obstet Gynecol 2003;188:1401–1405.
5. MitchellMF, SchottenfeldD, Zortolero-LunaG, et al. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1988;91:626–631.
6. HopmanEH, KenemansP, HelmerhorstTJ, et al. Positive predictive rate of colposcopic examination of the cervix uteri: an overview of literature. Gynecol Oncol Surv 1998;53:97–106.
7. BenedetJL, van de NiewenhofHP, NeeshamDE, et al. An analysis of 84 244 patients from British Columbia cytology–colposcopy program. Gynecol Oncol 2004;92:127–134.
8. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383–1392.
9. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of low grade squamous intraepithelial lesion. Am J Obstet Gynecol 2003;188:1393–1400.
10. MassadLS, HalperinCJ, BittermanP. Correlation between colposcopically directed biopsy and cervical loop excision. Gynecol Oncol 1996;60:400–403.
11. MassadLS, JeronimoJ, KatkiHA, SchiffmanM. The accuracy of colposcopic grading for detection of high grade cervical intraepithelial neoplasia. J Low Genit Tract Dis 2009;13:137–144.
12. PretoriusRG, ZhangWH, BelinsonJL, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004;191:430–434.
13. BenedetJL, MatisicJP, BertrandMA. The quality of community colposcopic practice. Obstet Gynecol 2004;103:545–548.
14. SideriM, SplotiN, SpinaciL. et al. Interobserver variability of colposcopic interpretations and consistency with final histologic results. J Low Genit Tract Dis 2004;8:212–216.
15. BekkersRL, van de NieuwenhofHP, NeeshamDE, et al. Does experience in colposocopy improve identification of high grade abnormalities?Eur J Obstet Gynecol Reprod Biol 2008;141:75–78.
16. HopmanEH, VoorhostFJ, KenemansP, et al. Observer agreement on interpreting colposcopic images of CIN. Gynecol Oncol 1995;58:206–209.
17. GageJC, HansonVw, AbbeyK, for the ALTS Group. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264–268.
18. NamK, ChungS, KwakJ, et al. Random biopsy after colposcopy-directed biopsy improves the diagnosis of cervical intraepithelial neoplasia grade 2 or worse. J Low Genit Tract Dis 2010;14:346–351.
19. ReidR, StanttopeCR, HerschmanBR, et al. Genital warts and cervical cancer. 4. A colposcopic index for differentiating subclinical papillomaviral infection from cervical intraepithelial neoplasia. Am J Obstet Gynecol 1984;149:815–823.
20. ReidR, HerschmanBR, CrumCP, et al. Genital warts and cervical cancer. 5. The tissue basis of colposcopic change. Am J Obstet Gynecol 1984;149:293–303.
21. ReidR, ScaiziP. Genital warts and cervical cancer. 7. An improved colposcopic index for differentiating benign papillomaviral infections from high-grade cervical intraepithelial neoplasia. Am J Obstet Gynecol 1985;153:611–618.
22. RubinM. Follow-up of an abnormal Pap test and colposcopy. In WallisLA (ed.) Textbook of Women’s Health. Philadelphia, PA: Lippincott-Raven, 1998, p. 901.
23. ApgarBS, BrotzmanGL, SpitzerM, et al. Colposcopy: Principles and Practice Textbook and Atlas. Philadelphia, PA: Saunders, 2002.
24. ChaseD, KalouyanM, DisaiaPJ. Colposcopy to evaluate abnormal cervical cytology in 2008. Am J Obstet Gynecol 2009;201:472–480.
25. MousaviAS, FakourR, GillaniMM, et al. A prospective study to evaluate the correlation between Reid colposcopic index impression and biopsy histology. J Low Genit Tract Dis 2007;11:147–150.
26. FerrisDG, LitakerM. Interobserver agreement for colposcopy quality control using digitized colposcopic images during ATLS trial. J Low Genit Tract Dis 2005;9:29–35.
27. FerrisDG, LitakerMSfor the ALTS Group. Prediction of cervical histologic results using an abbreviated Reid colposcopic index during ALTS. Am J Obstet Gynecol 2006;194:704–710.
28. OsterAGNatural History of CIN: a critical review. Int J Gynecol Pathol 1993;12:186–192.
29. KurmanRJ, MalkasianGD, SedlisA, et al. From Papanicolaou to Bethesda: the rationale for a new cervical cytology classification. Obstet Gynecol 1991;77:779–782.
30. ALTS Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from randomized trial. JNCI 2000;92:397–402.
31. MoscickiAB, ShiboskiS, BroeringJ, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277–284.
32. SchiffmanM, WetzensenN. From human papillomavirus to cervical cancer. Obstet Gynecol 2010;116:177–185.
33. KiviatN. Natural history of cervical neoplasia: overview and update. Am J Obstet Gynecol 1996;175:1099–1104.
34. CuzickJ, SzarewskiA, TerryG, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995;345:1533–1536.
35. ParkTW, RichartRM, SunXW, WrightTC. Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. JNCI 1996;88:317–318.
36. KoutskyLA, HolmesKK, CritchlowCW, et al. Cohort study of risk of cervical intraepithelial neoplasia grade 2 or 3 associated with cervical papillomavirus infection. N Engl J Med 1992;327:1272–1278.
37. DalySF, DoyleM, EnglishJ, et al. Can the number of cigarettes smoked predict high-grade cervical intraepithelial neoplasia among women with mildly abnormal cervical smears?Am J Obstet Gynecol 1998;179:399–402.
38. BrissonJ, MorinC, FortierM, et al. Risk factors for cervical intraepithelial neoplasia: differences between low and high-grade lesions. Am J Epidemiol 1994;140:700–710.
39. HoGY, KadishAS, BurkRD, et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intraepithelial neoplasia, Int J Cancer 1998;78:281–285.
40. Roteli-MartinsCM, PanettaK, AlvesVA, et al. Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand 1998;77:678–682.
41. GiulianoAR, PapenfussM, SchneiderA, et al. Risk factors for high-risk type papillomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev 1999;8:615–620.
42. IsmailSM, ColcloughAB, DinnenJS, et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ 1989;298:707–710.
43. ParakevaidisE, KitchenerHC, MillerID, et al. A population-based study of microinvasive disease of the cervix – a colposcopic and cytologic analysis. Gynecol Oncol 1992;45:9–12.
44. HopmanEH, KenemansP, HelmerhorstTJM. Positive predictive rate of colposcopic examination of the cervix uteri: an overview of literature. Obstet Gynecol Surv 1998;53:97–106.
45. LiuWM, ChaoKC, WangKI, et al. Colposcopic assessment in microinvasive carcinoma of the cervix. Chin Med J 1989;43:171–176.
46. YoonessiM, WieckowskaW, MarinielloD, et al. Cervical intraepithelial neoplasia in pregnancy. Int J Gynecol Obstet 1982;20:111–118.
47. LurainJR, GallupDG. Management of abnormal Papanicolaou smears in pregnancy. Obstet Gynecol 1979;53:484–488.
48. NevinJ, SoetersR, DehaeckK, et al. Cervical carcinoma associated with pregnancy. Obstet Gynecol Surv 1995;50:228–239.
49. GreerBE, GoffBA, KohWJ, et al. Cancer in the pregnant patient. In HoskinsWJ, PerezCA, YoungRC (eds.) Principles and Practice of Gynecologic Oncology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1997, p. 463.
50. WrightTC, MassadSL, DuntonCJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007: 346–355.
51. MassadLS, EinsteinMH, et al. Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013;121:829–846.
52. KaplanKJ, Dainty LA DolinksyB, RoseGS, et al. Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesions diagnosed during pregnancy. Cancer 2004;102:228–232.
53. OstergardDR. The effect of pregnancy on the cervical squamocolumnar junction in patients with abnormal cervical cytology. Am J Obstet Gynecol 1979;134:759–760.
54. HanniganEV, WhitehouseHH, AtkinsonWD, et al. Cone biopsy during pregnancy. Obstet Gynecol 1982;60:450–455.
55. LarssonG, GrunsdellH, GullbergB, et al. Outcome of pregnancy after conization. Acta Obstet Gynecol Scand 1982;61:461–466.
56. KiguchiK, BibboM, HasegawaT, et al. Dysplasia during pregnancy: a cytologic follow-up study. J Reprod Med 1981;26:66–72.
57. YostNP, SantosoJT, McIntireDD, IliyaFA. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol 1999;93:359–362.
58. KaplanKJ, DaintyLA, DolinskyB, et al. Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesions diagnosed during pregnancy. Cancer 2004;102:228–232.
59. HackerNF, BerekJS, LagasseLD, et al. Carcinoma of the cervix associated with pregnancy. Obstet Gynecol 1982;59:735–746.
60. WinerRL, FengQ, HughesJP, et al. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008;197:279–282.
61. WinerRL, LeeSK, HughesJP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218–226.
62. MoscikiAB, EllenburgJH, VermundSH, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 2000;154:127–134.
63. ForhanSE, GottliebSL, SternbergMR, et al. Prevalence of sexually transmitted infections among female adolescents aged 14–19 in the United States. Pediatrics 2009;124:1505–1512.
64. MoscickiAB. Impact of HPV infection in adolescent populations. J Adolesc Health 2005;37(Suppl):S3–S9.
65. SaslowD, SolomonD, LawsonHW. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis 2012;16:175–204.
66. Freeman-WangT, WalkerP. Colposcopy in special circumstances: Pregnancy, immunocompromise, including HIV and transplants, adolescence and menopause. Best Pract Res Clin Obstet Gynecol 2011;25:653–665.
67. UNAIDS. UNAIDS Report on Global AIDS Epidemic. New York: UNAIDS, 2010.
68. MaimanM. Management of cervical neoplasia in human immunodeficiency virus infected women. JNCI Monogr 1998;23:43–49.
69. DuerrA, ParamsothyP, JamiesonDJ, et al. HIV Epidemiology Research Study. Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis 2006;42:855–861.
70. SunXW, KuhnL, EllerbrockTV, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343–1349.
71. PalefskyJM, MinkoffH, KalishLA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. JNCI 1999;91:226–236.
72. BrancaM, DelfinoA, RossiE, et al. Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women. Eur J Gynaecol Oncol 1995;16:410–417.
73. PantanowitzL, MichelowP. Review of human immunodeficiency virus and squamous lesions of the uterine cervix. Diagn Cytopath 2010;39:65–72.
74. ChirenjeZM. HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol 2005;19:269–276.
75. MassadLS, AhdiehL, BenningL, et al. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women’s interagency HIV study. J Acquire Immune Defic Syndr 2001;27:432–442.
76. SchragerLK, FriedlandGH, MaudeD, et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1989;2:570–575.
77. SchaferA, FriedmannW, MielkeM, et al. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991;164:593–599.
78. VermundSH, KelleyKF, KleinRS, et al. High risk of human papillomavirus infection and squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1992;165:392–400.
79. MandelbattJS, FahsM, GaribaldiK, et al. Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for conditions. AIDS 1992;6:173–178.
80. KleinRS, HoGYF, VermundSH, et al. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 1994;170:1404–1409.
81. MassadLS, FazzariMJ, AnastosK, et al. Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis 2007;11:90–97.
82. FruchterRG, MaimanM, SedlisA, et al. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338–344.
83. FoulotH, HeadI, PotardV, CostagliolaD, ChapronC. Surgical management of cervical intraepithelial neoplasia in HIV-infected women. Eur J Obstet Gynecol Reprod Biol 2008;141:153–157.
84. ReimersLL, SotardiS, DanielD, et al. Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected women. Gynecol Oncol 2010;119:92–97.
85. HalpertR, FruchterRG, SedlisA, et al. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986;68:251–258.
86. PennJ. Cancers in cyclosporine-treated vs. azathioprine treated patients. Transplant Proc 1996;28:876–878.
87. SavaniBN, StrattonP, ShenoyA, et al. Increased risk of cervical dysplasia in long term survivors of allogeneic stem cell transplantation- implications for screening and HPV vaccination. Biol Blood Marrow Transplant 2008;14:1072–1095.
88. KlumbEM, AraujoML Jr., JesusGR, et al. Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression?J Clin Rheumatol 2010;16:153–157.
89. SinghH, DemersAA, NugentZ, et al. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case control study. Gastroenterology 2009;136:451–458.
90. US Department of Health and Human Services. Treatment of Opportunistic Infections. Washington, DC: US Department of Health and Human Services, National Institutes of Health, CDC, 2006.
91. WrightTC, Jr., MassadLS, DuntonCJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201–222.
92. BowerM, CollinsS, CottrillC., et al. AIDS Malignancy Subcomittee. British HIV Association guidelines for HIV-associated malignancies 2008. HIV Med 2008;9:336–388.
93. HerbstAL, UlfelderH, PoskancerDC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284–878.
94. JefferiesJA, RobboySJ, O’BrienPC, et al. Structural anomalies of the cervix and vagina in women enrolled in the diethylstilbestrol adenosis (DESAD) project. Am J Obstet Gynecol 1984;148:59–66.
95. KatkiHA, SchiffmanM, CastlePE, et al. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Low Genit Tract Dis 2013;17(Suppl 1):S28–S35.
96. DarraghTM, ColganTJ, CoxJT, et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions:background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch of Pathol Lab Med 2012;136:1266–1297.